Literature DB >> 1697931

A small v-sis/platelet-derived growth factor (PDGF) B-protein domain in which subtle conformational changes abrogate PDGF receptor interaction and transforming activity.

N Giese1, W J LaRochelle, M May-Siroff, K C Robbins, S A Aaronson.   

Abstract

Deletion scanning mutagenesis within the transforming region of the v-sis oncogene was used to dissect structure-function relationships. Mutations affecting codons within a domain encoding amino acids 136 through 148 had no effect upon homodimer formation or recognition by antisera which detect determinants dependent upon native intrachain disulfide linkages, yet the same mutations completely abolished transforming activity. A platelet-derived growth factor B (PDGF B) monoclonal antibody that prevents its interaction with PDGF receptors recognized v-sis, delta 142 (deletion of codon 142), and delta 148 but not delta 136, delta 137, or delta 139 mutants. These findings mapped the epitope recognized by this monoclonal antibody to include amino acid residues 136 to 139. Furthermore, mutations in the codon 136 to 148 domain caused markedly impaired ability to induce PDGF receptor tyrosine phosphorylation. Thus, subtle conformational alterations in this small domain critically affect PDGF receptor recognition and/or functional activation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697931      PMCID: PMC361263          DOI: 10.1128/mcb.10.10.5496-5501.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor.

Authors:  L Claesson-Welsh; A Eriksson; B Westermark; C H Heldin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

2.  Ligand-induced dimerization of the platelet-derived growth factor receptor. Monomer-dimer interconversion occurs independent of receptor phosphorylation.

Authors:  S Bishayee; S Majumdar; J Khire; M Das
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

3.  Two different subunits associate to create isoform-specific platelet-derived growth factor receptors.

Authors:  R A Seifert; C E Hart; P E Phillips; J W Forstrom; R Ross; M J Murray; D F Bowen-Pope
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

4.  Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes.

Authors:  T Matsui; M Heidaran; T Miki; N Popescu; W La Rochelle; M Kraus; J Pierce; S Aaronson
Journal:  Science       Date:  1989-02-10       Impact factor: 47.728

5.  The role of individual cysteine residues in the structure and function of the v-sis gene product.

Authors:  N A Giese; K C Robbins; S A Aaronson
Journal:  Science       Date:  1987-06-05       Impact factor: 47.728

Review 6.  The biology of platelet-derived growth factor.

Authors:  R Ross; E W Raines; D F Bowen-Pope
Journal:  Cell       Date:  1986-07-18       Impact factor: 41.582

7.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

8.  Identification of nonessential disulfide bonds and altered conformations in the v-sis protein, a homolog of the B chain of platelet-derived growth factor.

Authors:  M K Sauer; D J Donoghue
Journal:  Mol Cell Biol       Date:  1988-03       Impact factor: 4.272

9.  Vascular permeability factor, an endothelial cell mitogen related to PDGF.

Authors:  P J Keck; S D Hauser; G Krivi; K Sanzo; T Warren; J Feder; D T Connolly
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

Review 10.  Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity.

Authors:  B K Kobilka; T S Kobilka; K Daniel; J W Regan; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

View more
  4 in total

1.  Purification and analysis of proteinase-resistant mutants of recombinant platelet-derived growth factor-BB exhibiting improved biological activity.

Authors:  A L Cook; P M Kirwin; S Craig; L J Bawden; D R Green; M J Price; S J Richardson; A Fallon; A H Drummond; R M Edwards
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

2.  Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein.

Authors:  A N Meyer; Y F Xu; M K Webster; A E Smith; D J Donoghue
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

3.  Crystal structure of human platelet-derived growth factor BB.

Authors:  C Oefner; A D'Arcy; F K Winkler; B Eggimann; M Hosang
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

4.  Two PDGF-B chain residues, arginine 27 and isoleucine 30, mediate receptor binding and activation.

Authors:  J M Clements; L J Bawden; R E Bloxidge; G Catlin; A L Cook; S Craig; A H Drummond; R M Edwards; A Fallon; D R Green
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.